
Tetrahedron p. 8471 - 8482 (1993)
Update date:2022-07-30
Topics:
Sanz-Cervera, Juan F.
Glinka, Tomasz
Williams, Robert M.
A <13C>labeled hypothetical intermediate metabolite that was invoked by Birch in the biogenesis of brevianamides A and B has been synthesized and used in a biosynthetic feeding experiment.No incorporation of this substance was evident nor could it be detected in culture extracts of the producting organism Penicillium brevicompactum.In contrast with this, <3H>labeled deoxybrevianamide E was shown to be efficiently incorporated in brevianamides A, B, and E, while <3H>labeled brevianamide E was not incorporated at all in these substances.Moreover, brevianamide E has been found not to be an artifact, in contrast with an earlier suggestion found in the literature.These results are discussed in terms of an alternative biosynthetic pathway for the brevianamides.
View MoreShanghai KFSL Pharmaceutical Technology Co.,Ltd.
Contact:+86-21-39971718
Address:859 jiadingchengliu shanghai
Chengdu Aslee Biopharmaceuticals, Inc
Contact:18608018419
Address:Chengdu Aslee Biopharmaceuticals, Inc
Contact:86-15588110016
Address:LINYI CITY,SHANDONG PROVINCE,CHINA
SuZhou Ascepion Pharmaceuticals, Inc.(expird)
Contact:0512-86881668
Address:Building C,68Xingqing Road,Suzhou,China.
Global United Biotechnology Inc.
Contact:+86-21-61618568
Address:Room 309, Building 6, NO.135, Jinyu Road, Pudong
Doi:10.1021/ja01264a003
(1942)Doi:10.1039/jr9550002896
(1955)Doi:10.1021/ja01140a059
(1952)Doi:10.1002/hlca.19490320408
()Doi:10.1093/oxfordjournals.jpart.a003539
()Doi:10.1021/om50003a020
(1983)